Melissa Burgess

9PUBLICATIONS
97CO-AUTHORS
Animal systematics and taxonomyMolecular targetsHaematological tumoursSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

|Jan 15, 2026
Validation of a Seven-Gene Predictive SIGNature for the Efficacy of Immuno-Oncology PD-1 Inhibitors in Patients with Sarcoma.

David S Moura, Jesus Lopez-Marti, Hussein Tawbi

|Jul 08, 2025
SARC028 Samples Reveal an Interplay between TGF-β, IFN Signaling, and Low HLA Class I Expression as Contributors to Ewing Sarcoma Checkpoint Blockade Resistance.

Jessica D Daley, Elina Mukherjee, David Ferraro

|Mar 06, 2024
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.

Scott M Schuetze, Karla V Ballman, Rachel Heise

|Jul 19, 2023
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250).

Matthew Ingham, Jacob B Allred, Li Chen

|Jun 29, 2023
Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma.

Patrick Schöffski, Rastislav Bahleda, Andrew J Wagner

Pageof 2